Datasheets Replacement Solutions
RFQ / BOM 0 Sign In / Register

Select Your Location

VOS617AT

vishay IC Chips SSOP4

VOS617AT
  • VOS617AT
  • play
    product video

Images are for reference only.
See Product Specifications for product details.

Social Media

VOS617AT

vishay IC Chips SSOP4

Orders over $200 are eligible for a limited edition Chinese-style gift.

Orders over $200 are eligible for a limited edition Chinese-style gift.

Orders over $1000 qualify for a $30 shipping fee waiver.

Orders surpassing $5000 enjoy waived shipping and transaction fees.

These offers are applicable to both new and existing customers and are valid from January 1st, 2024, to December 31st, 2024.

  • Manufacturer：

    vishay

  • Datasheet：

    VOS617AT datasheet

  • Package/Case：

    SSOP4

  • Product Category：

    IC Chips

  • RoHS Status： RoHS Status Lead free/RoHS Compliant

Submit your quote request now, and we expect to provide a quote within July 04, 2024. Place your order now, and we expect to complete the transaction within July 09, 2024. Ps:Time is according to GMT+8:00.

Delivery：
fedex ups ems dhl other
Payment ：
jcb American express tt discover paypal

Stock：28695 PCS

Our commitment is to deliver prompt quotations within 12 hours. For further assistance, please contact us at [email protected].

VOS617AT Product Details

Request a quote VOS617AT at censtry.com. All items are new and original with 365 days warranty! The excellent quality and guaranteed services of VOS617AT in stock for sale, check stock quantity and pricing, view product specifications, and order contact us：[email protected].
The price and lead time for VOS617AT depending on the quantity required, please send your request to us, our sales team will provide you price and delivery within 24 hours, we sincerely look forward to cooperating with you.

Direction：

The journey of VOS617AT from innovative concept to potential treatment breakthrough showcases its remarkable capacity to modulate cellular responses to hypoxia through targeted HIF-PH inhibition. With a focus on ameliorating anemic conditions and ischemic diseases, this compound holds immense promise for patients seeking relief from the burden of low oxygen levels. Initial clinical trials have highlighted its favorable safety and tolerability profiles, laying the groundwork for further investigation into its therapeutic efficacy. By exploring the potential benefits of once-daily dosing regimens and expanding its reach to larger patient populations, VOS617AT paves the way for a new era of precision medicine in the realm of hypoxia-related disorders

VOS617AT Related Products

Q&A for VOS617AT